date,title,source
Oct-19-18,Merrimack's String of Failures Continues With Lung Cancer Study Shelved After Midstage Trials,Benzinga
Oct-19-18,Merrimack Pharmaceuticals' stock plummets toward record low after cancer drug trial terminated,MarketWatch
Oct-19-18,Merrimack Discontinues Phase 2 SHERLOC Study of MM-121 in Patients with Non-Small Cell Lung Cancer Due to Futility,PR Newswire
